These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 20689430)

  • 21. [Imaging of gliomas].
    Martin-Duverneuil N; Guillevin R; Chiras J
    Cancer Radiother; 2008 Nov; 12(6-7):669-75. PubMed ID: 18922727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A changing paradigm of glioma biology.
    Shapiro WR; Shapiro JR
    Hematol Oncol Clin North Am; 2006 Dec; 20(6):1171-91. PubMed ID: 17113458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of angiogenesis and invasion in malignant gliomas.
    Chi A; Norden AD; Wen PY
    Expert Rev Anticancer Ther; 2007 Nov; 7(11):1537-60. PubMed ID: 18020923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas.
    Wong ML; Prawira A; Kaye AH; Hovens CM
    J Clin Neurosci; 2009 Sep; 16(9):1119-30. PubMed ID: 19556134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Application of diffusion tensor imaging in preoperation and postoperation patients of glioma with 3.0 Tesla MRI].
    Li X; Yu RT; Xu K; Li FC; Fan YC; Gao WC; Guo KQ; Pan X; Yang C
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(19):1300-4. PubMed ID: 19615179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diffusion tensor imaging for preoperative evaluation of tumor grade in gliomas.
    Inoue T; Ogasawara K; Beppu T; Ogawa A; Kabasawa H
    Clin Neurol Neurosurg; 2005 Apr; 107(3):174-80. PubMed ID: 15823671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric high-grade gliomas and diffuse intrinsic pontine gliomas.
    Fangusaro J
    J Child Neurol; 2009 Nov; 24(11):1409-17. PubMed ID: 19638636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endogenous growth inhibition of angiogenesis in brain tumors.
    Kirsch M; Allende R; Black P; Schackert G
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):469-79. PubMed ID: 17960325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Posttreatment evaluation of central nervous system gliomas.
    Shiroishi MS; Booker MT; Agarwal M; Jain N; Naghi I; Lerner A; Law M
    Magn Reson Imaging Clin N Am; 2013 May; 21(2):241-68. PubMed ID: 23642552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in neuroimaging techniques for the evaluation of tumor growth, vascular permeability, and angiogenesis in gliomas.
    Gerstner ER; Sorensen AG; Jain RK; Batchelor TT
    Curr Opin Neurol; 2008 Dec; 21(6):728-35. PubMed ID: 18989120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of multifocal and multicentric gliomas.
    Patil CG; Eboli P; Hu J
    Neurosurg Clin N Am; 2012 Apr; 23(2):343-50, x. PubMed ID: 22440877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Introduction: recent advances in the biology and treatment of low- grade gliomas.
    Tsien C
    Semin Radiat Oncol; 2015 Jul; 25(3):153-4. PubMed ID: 26050584
    [No Abstract]   [Full Text] [Related]  

  • 33. Radiology: criteria for determining response to treatment and recurrence of high-grade gliomas.
    Lucas J; Zada G
    Neurosurg Clin N Am; 2012 Apr; 23(2):269-76, viii. PubMed ID: 22440870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endostatin "cell factories" shrink rodent brain tumors.
    Brower V
    Trends Mol Med; 2001 Mar; 7(3):97-8. PubMed ID: 11286765
    [No Abstract]   [Full Text] [Related]  

  • 35. Assessing Response of High-Grade Gliomas to Immune Checkpoint Inhibitors.
    Sahebjam S; Stallworth DG; Mokhtari S; Tran ND; Arrington JA
    Cancer Control; 2017 Apr; 24(2):180-186. PubMed ID: 28441372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Editorial: Advances in biology and treatment of malignant brain gliomas. Stem cells and neurosciences.
    Maira G; Fernandez E
    Neurol Res; 2006 Jul; 28(5):471-3. PubMed ID: 16808874
    [No Abstract]   [Full Text] [Related]  

  • 37. Current and future strategies for treatment of glioma.
    Bush NA; Chang SM; Berger MS
    Neurosurg Rev; 2017 Jan; 40(1):1-14. PubMed ID: 27085859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preface. Modern management of high grade glioma, Part I.
    Yang I; Han SJ
    Neurosurg Clin N Am; 2012 Apr; 23(2):xiii. PubMed ID: 22440878
    [No Abstract]   [Full Text] [Related]  

  • 39. Imaging biomarkers for antiangiogenic therapy in malignant gliomas.
    Leu K; Pope WB; Cloughesy TF; Lai A; Nghiemphu PL; Chen W; Liau LM; Ellingson BM
    CNS Oncol; 2013 Jan; 2(1):33-47. PubMed ID: 24570837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modern molecular approaches to diagnosis and treatment of high-grade brain gliomas.
    Pavlova GV; Baklaushev VP; Ivanova MA; Goriaĭnov SA; Rybalkina EI; Kopylov AM; Chekhonin VP; Potapov AA; Konovalov AN
    Zh Vopr Neirokhir Im N N Burdenko; 2014; 78(6):85-100. PubMed ID: 25874291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.